Back to search

Ireland· IE-PA-EU/1/98/095/001

EMADINE 0.5 mg/ml, eye drops, solution

A emedastine product containing emedastine difumarate, registered in Ireland by Immedica Pharma AB. The same ATC class is registered in 12 of our 19 countries.

ATC S01GX06

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedEMADINE 0.5 mg/ml, eye drops, solutionATCS01GX06REGISTER NO.IE-PA-EU/1/98/095/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Emedastine is registered in 12 of 19 countries.

Countries holding a registration under ATC S01GX06 (emedastine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Emedastine · ATC S01GX06

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Emedastine difumarate
Manufacturer
Immedica Pharma AB
Country
Ireland (IE)
ATC code
S01GX06
ATC class
Emedastine
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/98/095/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emedastine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emedastine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de29ca2c-ceaa-4a01-8342-636a0c1f245a
GET /v1/drugs/de29ca2c-ceaa-4a01-8342-636a0c1f245a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "routes": [
    "Ocular use"
  ],
  "source": "hpra",
  "atc_all": [
    "S01GX",
    "S01GX06"
  ],
  "strength": null,
  "pa_number": "EU/1/98/095/001",
  "substances": [
    "Emedastine difumarate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "27/01/1999",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about emedastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.